IRADIMED CORPORATION Operating Lease Cost
IRADIMED CORPORATION (IRMD) reported Operating Lease Cost of $489.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-03-06
- IRADIMED CORPORATION operating lease, cost for the quarter ending 2025-06-30 was $188.90K, a 7.41% decline year-over-year.
- IRADIMED CORPORATION operating lease, cost for the quarter ending 2025-03-31 was $178.48K, a 12.23% decline year-over-year.
- IRADIMED CORPORATION operating lease, cost for the quarter ending 2024-12-31 was $337.44K, a 61.76% increase year-over-year.
- IRADIMED CORPORATION operating lease, cost for the quarter ending 2024-09-30 was $160.27K, a 1.45% increase year-over-year.
- IRADIMED CORPORATION operating lease, cost for fiscal 2025 was $489.00K, a 40.15% decline from fiscal 2024.
- IRADIMED CORPORATION operating lease, cost for fiscal 2024 was $817.00K, a 21.00% increase from fiscal 2023.
- IRADIMED CORPORATION operating lease, cost for fiscal 2023 was $675.19K, a 26.33% increase from fiscal 2022.
- IRADIMED CORPORATION operating lease, cost for fiscal 2022 was $534.47K, a 14.31% increase from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $489.00K 10-K · filed 2026-03-06 | ||||
| 2025-06-30 | $188.90K 10-Q · filed 2025-08-01 | $367.38K 10-Q · filed 2025-08-01 | $704.82K derived: sum of 3 quarters · filed 2026-03-06 | $865.08K derived: sum of 4 quarters · filed 2026-03-06 | |
| 2025-03-31 | $178.48K 10-Q · filed 2025-05-05 | $515.92K derived: sum of 2 quarters · filed 2026-03-06 | $676.18K derived: sum of 3 quarters · filed 2026-03-06 | $880.19K derived: sum of 4 quarters · filed 2026-03-06 | |
| 2024-12-31 | $337.44K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $497.70K derived: sum of 2 quarters · filed 2026-03-06 | $701.71K derived: sum of 3 quarters · filed 2026-03-06 | $817.00K 10-K · filed 2026-03-06 | $816.93K 10-K · filed 2025-03-06 |
| 2024-09-30 | $160.27K 10-Q · filed 2024-10-31 | $364.27K derived: sum of 2 quarters · filed 2025-08-01 | $479.56K 10-Q · filed 2024-10-31 | $776.23K derived: sum of 4 quarters · filed 2025-09-03 | |
| 2024-06-30 | $204.01K 10-Q · filed 2025-08-01 | $407.36K 10-Q · filed 2025-08-01 | $615.96K derived: sum of 3 quarters · filed 2025-09-03 | $773.94K derived: sum of 4 quarters · filed 2025-09-03 | |
| 2024-03-31 | $203.35K 10-Q · filed 2025-05-05 | $411.95K derived: sum of 2 quarters · filed 2025-09-03 | $569.93K derived: sum of 3 quarters · filed 2025-09-03 | $732.48K derived: sum of 4 quarters · filed 2025-09-03 | |
| 2023-12-31 | $208.60K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-03 | $366.58K derived: sum of 2 quarters · filed 2025-09-03 | $529.13K derived: sum of 3 quarters · filed 2025-09-03 | $675.19K 10-K/A · filed 2025-09-03 | |
| 2023-09-30 | $157.98K 10-Q · filed 2024-10-31 | $320.53K derived: sum of 2 quarters · filed 2024-10-31 | $466.59K 10-Q · filed 2024-10-31 | $651.99K derived: sum of 4 quarters · filed 2024-10-31 | |
| 2023-06-30 | $162.55K 10-Q · filed 2024-08-01 | $324.36K 10-Q · filed 2024-08-01 | $494.01K derived: sum of 3 quarters · filed 2024-08-01 | $621.82K derived: sum of 4 quarters · filed 2024-08-01 | |
| 2023-03-31 | $161.81K 10-Q · filed 2024-05-02 | $331.46K derived: sum of 2 quarters · filed 2024-05-02 | $459.27K derived: sum of 3 quarters · filed 2024-05-02 | $579.20K derived: sum of 4 quarters · filed 2024-05-02 | |
| 2022-12-31 | $169.64K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $297.46K derived: sum of 2 quarters · filed 2024-03-01 | $417.39K derived: sum of 3 quarters · filed 2024-03-01 | $534.47K 10-K · filed 2024-03-01 | |
| 2022-09-30 | $127.82K 10-Q · filed 2023-11-03 | $247.75K derived: sum of 2 quarters · filed 2023-11-03 | $364.82K 10-Q · filed 2023-11-03 | $487.60K derived: sum of 4 quarters · filed 2023-11-03 | |
| 2022-06-30 | $119.93K 10-Q · filed 2023-08-03 | $239.86K 10-Q · filed 2023-08-03 | $359.79K derived: sum of 3 quarters · filed 2023-08-03 | $479.71K derived: sum of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | $119.93K 10-Q · filed 2023-05-04 | $239.86K derived: sum of 2 quarters · filed 2023-05-04 | $359.79K derived: sum of 3 quarters · filed 2023-05-04 | $475.07K derived: sum of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | $119.93K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $239.86K derived: sum of 2 quarters · filed 2023-03-02 | $355.14K derived: sum of 3 quarters · filed 2023-03-02 | $467.57K 10-K · filed 2023-03-02 | |
| 2021-09-30 | $119.93K 10-Q · filed 2022-11-03 | $235.21K derived: sum of 2 quarters · filed 2022-11-03 | $347.64K 10-Q · filed 2022-11-03 | $450.04K derived: sum of 4 quarters · filed 2022-11-03 | |
| 2021-06-30 | $115.28K 10-Q · filed 2022-08-05 | $227.72K 10-Q · filed 2022-08-05 | $330.11K derived: sum of 3 quarters · filed 2022-08-05 | $432.51K derived: sum of 4 quarters · filed 2022-08-05 | |
| 2021-03-31 | $112.43K 10-Q · filed 2022-05-06 | $214.83K derived: sum of 2 quarters · filed 2022-05-06 | $317.23K derived: sum of 3 quarters · filed 2022-05-06 | $419.63K derived: sum of 4 quarters · filed 2022-05-06 | |
| 2020-12-31 | $102.40K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $204.80K derived: sum of 2 quarters · filed 2022-03-04 | $307.19K derived: sum of 3 quarters · filed 2022-03-04 | $409.59K 10-K · filed 2022-03-04 | |
| 2020-09-30 | $102.40K 10-Q · filed 2021-11-05 | $204.80K derived: sum of 2 quarters · filed 2021-11-05 | $307.19K 10-Q · filed 2021-11-05 | $409.59K derived: sum of 4 quarters · filed 2022-03-04 | |
| 2020-06-30 | $102.40K 10-Q · filed 2021-08-06 | $204.80K 10-Q · filed 2021-08-06 | $307.19K derived: sum of 3 quarters · filed 2022-03-04 | $409.59K derived: sum of 4 quarters · filed 2022-03-04 | |
| 2020-03-31 | $102.40K 10-Q · filed 2021-05-07 | $204.80K derived: sum of 2 quarters · filed 2022-03-04 | $307.19K derived: sum of 3 quarters · filed 2022-03-04 | $409.59K derived: sum of 4 quarters · filed 2022-03-04 | |
| 2019-12-31 | $102.40K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $204.80K derived: sum of 2 quarters · filed 2022-03-04 | $307.19K derived: sum of 3 quarters · filed 2022-03-04 | $409.59K 10-K · filed 2022-03-04 | |
| 2019-09-30 | $102.40K 10-Q · filed 2020-11-06 | $204.80K derived: sum of 2 quarters · filed 2020-11-06 | $307.20K 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $102.40K 10-Q · filed 2020-08-06 | $204.80K 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | $102.40K 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |